In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
Date:
More like thisRelated
Women Sluggers Are No Longer in a League of Their Own
As a group of players from an all-women’s baseball...
Cleveland Guardians Make It Three Straight AL Central Titles
Once again, the Cleveland Guardians are division champs. Patrick...
4 Takeaways From Oregon Outlasting USC In Stunning West Coast Shootout
Skying into the Los Angeles night, Oregon receiver Dakorien...
Trump Promotes Criticism of Republican Who Broke With Him on Immigration
The president amplified negative social media comments about Representative...